Lunai Bioworks Inc. (RENB)
NASDAQ: RENB
· Real-Time Price · USD
1.42
0.00 (0.00%)
At close: Jun 09, 2025, 3:59 PM
Lunai Bioworks Cash Flow Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Net Income | 39,684B | -7.25M | -44.21M | -49.92M | -17.02M | -4.53M | -9.18M | -23.2M | -4.33M | -4.46M | -7.7K | -90.24M | -6.2M | -6.58M | -10.41M |
Depreciation & Amortization | -113.5B | 32.11K | 32.38K | 31.13K | 30.3K | 33.16K | 27.26K | 28.01K | 28.24K | 28.84K | n/a | 28.33K | 101.8K | 101.16K | 100.39K |
Stock-Based Compensation | -3,535B | 558.63K | 357.65K | 828.47K | 1.86M | 999.23K | 983.83K | 612.88K | 1.08M | 819.96 | 1.03K | n/a | n/a | n/a | n/a |
Other Working Capital | 527.12K | 255.47K | 259.65K | 1.75M | -1.65K | -1.65K | 16.24K | 157.52K | 148.00 | 149.00 | 220.98 | 931.78K | 263.76K | -42.39K | -820.95K |
Other Non-Cash Items | -36,035.4B | 3.13M | 39.79M | 42.95M | -256.11K | 196.65K | 4.64M | 352.76K | 74.62K | 1.08M | 3.77K | 84.45M | 2.61M | 2.87M | 5.6M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.32M | 972.72K | 2.02M | 3.7M | 4.33M | 153.46K | 628.95K | 982.99K | -158.56K | 149.48K | 217.00 | 1.85M | 584.03K | -423.51K | -592K |
Operating Cash Flow | -1.49M | -2.56M | -2.02M | -2.41M | -2.63M | -3.15M | -2.78M | -2.26M | -3.31M | -3.38M | -2.65K | -3.05M | -2.78M | -4.62M | -5.28M |
Capital Expenditures | 29.77B | n/a | n/a | -23.55K | -5.29K | -41.58K | n/a | -6.14K | n/a | -23.63K | n/a | n/a | n/a | n/a | -5.16K |
Cash Acquisitions | n/a | n/a | n/a | n/a | 65.85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -29.77B | n/a | n/a | -29.82K | -152.15K | -15.75K | -1.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.46M | n/a | n/a | -53.37K | -91.6K | -57.33K | -1.06M | -6.14K | n/a | -23.63K | n/a | n/a | n/a | n/a | -5.16K |
Debt Repayment | 3.58M | 2.51M | -67K | 4.4M | 1.64M | 2.5M | 562.82K | -280.77K | -374.37K | -300K | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -204K | n/a | -1.93M | n/a | 341.87K | n/a | n/a | n/a | n/a | -166.63K | 1.07M | -222.17K | 2.95M | n/a |
Financial Cash Flow | 3.58M | 2.59M | 2.03M | 2.47M | 2.64M | 2.85M | 2.56M | 1.25M | 2.11M | -466.63K | 1.46K | 1.07M | 229.53K | 2.95M | n/a |
Net Cash Flow | 611.24K | 91.19K | 104.00 | -92.23K | 68.72K | -279.49K | -1.35M | -1.07M | -1.17M | -3.85M | -1.2K | -1.98M | -2.56M | -1.67M | -5.28M |
Free Cash Flow | 11,804.3B | -2.56M | -2.02M | -2.44M | -2.64M | -3.19M | -2.78M | -2.27M | -3.31M | -3.41M | -2.65K | -3.05M | -2.78M | -4.62M | -5.28M |